CK-2017357

· Cytokinetics

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CK-2017357, covering 2019-05-03 to 2020-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]